2007 - Clinical Teacher Award, Infectious Disease Society of America
Daniel M. Musher mostly deals with Internal medicine, Immunology, Pneumonia, Streptococcus pneumoniae and Microbiology. The various areas that he examines in his Internal medicine study include Antibiotics, Antibacterial agent, Surgery, Cardiology and Gastroenterology. His Immunology research includes themes of Respiratory tract infections and Syphilis.
Daniel M. Musher combines subjects such as Heart failure, Intensive care medicine, Bacteremia, Severity of illness and Pneumococcal pneumonia with his study of Pneumonia. His biological study deals with issues like Community-acquired pneumonia, which deal with fields such as MEDLINE. His research investigates the connection with Microbiology and areas like Streptococcus which intersect with concerns in Streptococcaceae.
Microbiology, Immunology, Internal medicine, Pneumonia and Streptococcus pneumoniae are his primary areas of study. His Microbiology research is multidisciplinary, relying on both Staphylococcus aureus, Bacteria and Virology. His Immunology study integrates concerns from other disciplines, such as Pneumococcal vaccine and Pneumococcal polysaccharide vaccine.
His Internal medicine research is multidisciplinary, incorporating elements of Clostridium difficile, Surgery, Metronidazole, Gastroenterology and Bacteremia. His research in Pneumonia intersects with topics in Disease, Pneumococcal pneumonia and Intensive care medicine. His Community-acquired pneumonia study incorporates themes from Etiology and MEDLINE.
Daniel M. Musher mainly focuses on Pneumonia, Internal medicine, Community-acquired pneumonia, Intensive care medicine and Etiology. His work deals with themes such as Meningitis and Antibiotics, Streptococcus pneumoniae, Gram staining, which intersect with Pneumonia. His studies deal with areas such as Immunology, Gastroenterology and Pneumococcal pneumonia as well as Internal medicine.
His Community-acquired pneumonia research incorporates elements of Respiratory virus, MEDLINE, Antibiotic therapy, Procalcitonin and Coinfection. Daniel M. Musher has researched MEDLINE in several fields, including Guideline, Multidisciplinary approach, Severity of illness and Ambulatory care. His Intensive care medicine research incorporates themes from Empiric therapy, Antimicrobial stewardship, Respiratory Flora, Cellulitis and Disease.
His primary areas of study are Pneumonia, Internal medicine, Community-acquired pneumonia, Immunology and Etiology. His biological study spans a wide range of topics, including Antibiotics, Gram staining, MEDLINE, Guideline and Intensive care medicine. His studies in Intensive care medicine integrate themes in fields like Abscess, Incision and drainage, Medical literature, Emergency department and Antibiotic Stewardship.
His study ties his expertise on Pneumococcal pneumonia together with the subject of Internal medicine. His research integrates issues of Ambulatory care, Multidisciplinary approach, Procalcitonin and Severity of illness in his study of Community-acquired pneumonia. His Immunology research is multidisciplinary, incorporating perspectives in Meningitis and Hyponatremia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
Lionel A. Mandell;Richard G. Wunderink;Antonio Anzueto;John G. Bartlett.
Clinical Infectious Diseases (2007)
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
John G Bartlett;Scott F Dowell;Lionel A Mandell;Thomas M File.
Clinical Infectious Diseases (2000)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay;Grant W. Waterer;Ann C. Long;Antonio Anzueto.
American Journal of Respiratory and Critical Care Medicine (2019)
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
Lionel A. Mandell;John G. Bartlett;Scott F. Dowell;Thomas M. File.
Clinical Infectious Diseases (2003)
Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance: A Report From the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
James D. Heffelfinger;Scott F. Dowell;James H. Jorgensen;Keith P. Klugman.
JAMA Internal Medicine (2000)
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.
Scott Dowell;Jay Butler;G. Giebink;Michael Jacobs.
Pediatric Infectious Disease Journal (1999)
Infections Caused by Streptococcus pneumoniae: Clinical Spectrum, Pathogenesis, Immunity, and Treatment
Daniel M. Musher.
Clinical Infectious Diseases (1992)
Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.
Samuel A. Shelburne;Richard J. Hamill;Maria C. Rodriguez-Barradas;Stephen B. Greenberg.
Medicine (2002)
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
Feng-Yee Chang;James E. Peacock;Daniel M. Musher;Patricia Triplett.
Medicine (2003)
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole
Daniel M. Musher;Daniel M. Musher;Saima Aslam;Nancy Logan;Srikanth Nallacheru.
Clinical Infectious Diseases (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Houston Methodist
The University of Texas Health Science Center at Tyler
Johns Hopkins University School of Medicine
Bill & Melinda Gates Foundation
University of Barcelona
The University of Texas Health Science Center at Houston
National Center for Immunization and Respiratory Diseases
The University of Texas at Dallas
Intel (United States)
University of Minnesota
European Molecular Biology Laboratory
Forschungszentrum Jülich
King's College London
Cardiff University
Daegu Gyeongbuk Institute of Science and Technology
University of Kentucky
University of Dundee
Karolinska Institute
University of Melbourne
University College London
Johns Hopkins University
University of Helsinki
University of Michigan–Ann Arbor